PLN 50.9
(5.17%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 12.48 Million PLN | -95.76% |
2022 | 294.29 Million PLN | 52.31% |
2021 | 193.22 Million PLN | 99.6% |
2020 | 96.8 Million PLN | 6462.49% |
2019 | 1.47 Million PLN | -96.96% |
2018 | 48.58 Million PLN | 22.44% |
2017 | 39.68 Million PLN | -5.44% |
2016 | 41.96 Million PLN | 53.62% |
2015 | 27.31 Million PLN | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 2.47 Million PLN | -18.87% |
2024 Q2 | 67.79 Million PLN | 2675.2% |
2023 Q2 | 65.06 Million PLN | -1.84% |
2023 Q1 | 66.28 Million PLN | -11.12% |
2023 Q4 | 3.04 Million PLN | -95.05% |
2023 Q3 | 61.58 Million PLN | -5.34% |
2023 FY | 12.48 Million PLN | -95.76% |
2022 Q2 | 77.23 Million PLN | 13.59% |
2022 FY | 294.29 Million PLN | 52.31% |
2022 Q4 | 74.57 Million PLN | 0.1% |
2022 Q3 | 74.49 Million PLN | -3.54% |
2022 Q1 | 67.99 Million PLN | 19.37% |
2021 FY | 193.22 Million PLN | 99.6% |
2021 Q2 | 44.63 Million PLN | 1.11% |
2021 Q1 | 44.14 Million PLN | 63.49% |
2021 Q3 | 47.65 Million PLN | 6.76% |
2021 Q4 | 56.96 Million PLN | 19.53% |
2020 Q1 | 20.66 Million PLN | 2.69% |
2020 Q2 | 24.72 Million PLN | 19.62% |
2020 FY | 96.8 Million PLN | 6462.49% |
2020 Q4 | 27 Million PLN | 10.19% |
2020 Q3 | 24.5 Million PLN | -0.88% |
2019 Q2 | 187.58 Thousand PLN | -98.64% |
2019 Q1 | 13.77 Million PLN | 0.0% |
2019 FY | 1.47 Million PLN | -96.96% |
2019 Q4 | 20.12 Million PLN | 26819.35% |
2019 Q3 | 74.76 Thousand PLN | -60.14% |
2018 Q3 | 13.8 Million PLN | 0.0% |
2018 FY | 48.58 Million PLN | 22.44% |
2018 Q1 | 10.95 Million PLN | 0.0% |
2017 FY | 39.68 Million PLN | -5.44% |
2016 FY | 41.96 Million PLN | 53.62% |
2015 FY | 27.31 Million PLN | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
BioMaxima S.A. | 1.6 Million PLN | -677.397% |
Scope Fluidics S.A. | 2.41 Million PLN | -418.05% |
Voxel S.A. | 27.62 Million PLN | 54.813% |